Eton Pharmaceuticals, Inc. /
Teva Pharmaceuticals USA, Inc.
Eton Pharmaceuticals adds Galzin to its portfolio
What happened
Eton Pharmaceuticals, Inc. acquired Galzin from Teva Pharmaceuticals USA, Inc. on Dec. 31, 2024. Galzin is an FDA-approved zinc treatment for patients with Wilson Disease.
The purchase price was $7.0 million, with an additional $0.2 million paid for product inventory.
The source
Everything on this page comes from the source below.
Eton Pharmaceuticals adds Galzin to its portfolio
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly